[Compliance with biologic agents: Current situation].

L’observance des biothérapies : état des lieux.
Adherence Adhésion Biologic agents Biothérapie Compliance Education Éducation

Journal

Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 16 02 2021
accepted: 14 04 2021
pubmed: 19 6 2021
medline: 18 9 2021
entrez: 18 6 2021
Statut: ppublish

Résumé

Despite the fact that the prognosis of chronic inflammatory disorders is improved by biological agents, compliance with those therapeutics remains imperfect. Compliance corresponds to the measurable part of the follow-up of the medical prescription by the patient, whereas adherence is related to the acceptation of the treatment by the patient. The compliance rates of biologic agents are generally higher than those of conventional therapies. Compliance can be influenced by the real or experienced efficacity of the treatment, by patient-related factors or by the patient-physician relationship. An increase of compliance is associated with an improvement of adherence. To achieve this, the physician can use educational measures such as patient education, which allows the identification of poor adherence. Such programs have been shown to improve the patient's knowledge of the disease and treatment leading to better adherence and compliance.

Identifiants

pubmed: 34140211
pii: S0761-8425(21)00302-8
doi: 10.1016/j.rmr.2021.06.001
pii:
doi:

Substances chimiques

Biological Factors 0

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

698-705

Informations de copyright

Copyright © 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

S Ottaviani (S)

Service de rhumatologie, hôpital Bichat-Claude Bernard, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France. Electronic address: sebastien.ottaviani@aphp.fr.

M Forien (M)

Service de rhumatologie, hôpital Bichat-Claude Bernard, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH